Advertisement

Translational Stroke Research

, Volume 11, Issue 1, pp 1–3 | Cite as

Experimental Aneurysmal Subarachnoid Hemorrhage: Tiding Over

  • Marcel A. Kamp
  • Hans-Jakob Steiger
  • Jasper Hans van LieshoutEmail author
Letter to the Editor
  • 52 Downloads

Dear Editor,

Aneurysmal subarachnoid hemorrhage (aSAH) is a type of hemorrhagic stroke, which is associated with significant morbidity, and a case fatality of nearly 50% [6, 13, 17, 18]. Early brain injury (EBI) and delayed cerebral ischemia (DCI) are the two main determinants for functional outcome after aSAH. EBI refers to direct mechanical damage to the brain tissue and early pathophysiological changes, including increased intracranial pressure (ICP) and reduced cerebral perfusion. DCI describes a complex of reaction occurring thereafter [20]. Various mechanisms contribute to DCI, including angiographic cerebral vasospasms, microvascular spasm, microthrombosis, cortical spreading depolarization, failure of cerebral autoregulation, and inflammatory responses [20]. The individual importance of each of these pathomechanisms remains to be elucidated and it has been suggested that the etiology of EBI and DCI are linked. However, a unifying theory of these pathophysiological changes has...

Notes

Acknowledgments

We thank Christiane von Saß for careful reading of the manuscript.

Funding

This study is supported by MKMD grants from The Netherlands Organization for Health Research and Development (ZonMw Grand Numbers 114024130 and 114024137).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    D’Abbondanza JA, Ai J, Lass E, Wan H, Brathwaite S, Tso MK, et al. Robust effects of genetic background on responses to subarachnoid hemorrhage in mice. J Cereb Blood Flow Metab. 2015.  https://doi.org/10.1177/0271678X15612489.CrossRefGoogle Scholar
  2. 2.
    D’Abbondanza JA, Lass E, Ai J, Loch Macdonald R. Mouse genetic background is associated with variation in secondary complications after subarachnoid hemorrhage. Acta Neurochir Suppl. 2015;120:29–33.  https://doi.org/10.1007/978-3-319-04981-6_5.CrossRefPubMedGoogle Scholar
  3. 3.
    Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2011;31:1443–51.  https://doi.org/10.1038/jcbfm.2011.7.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Hijdra A, Van Gijn J, Stefanko S, Van Dongen KJ, Vermeulen M, Van Crevel H. Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: clinicoanatomic correlations. Neurology. 1986;36:329–33.CrossRefGoogle Scholar
  5. 5.
    Hooijmans CR, Ritskes-Hoitinga M. Progress in using systematic reviews of animal studies to improve translational research. PLoS Med. 2013;10:e1001482.  https://doi.org/10.1371/journal.pmed.1001482.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997;28:660–4.CrossRefGoogle Scholar
  7. 7.
    Kamp MA, Lieshout JH, Dibue-Adjei M, Weber JK, Schneider T, Restin T, et al. A systematic and meta-analysis of mortality in experimental mouse models analyzing delayed cerebral ischemia after subarachnoid hemorrhage. Transl Stroke Res. 2017.  https://doi.org/10.1007/s12975-016-0513-3.CrossRefGoogle Scholar
  8. 8.
    Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.  https://doi.org/10.1371/journal.pbio.1000412.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, National Centre for the Replacement R, et al. Animal research: reporting in vivo experiments--the ARRIVE guidelines. J Cereb Blood Flow Metab. 2011;31:991–3.  https://doi.org/10.1038/jcbfm.2010.220.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Lapchak PA, Zhang JH. Data standardization and quality management. Transl Stroke Res. 2018;9:4–8.  https://doi.org/10.1007/s12975-017-0531-9.CrossRefPubMedGoogle Scholar
  11. 11.
    Lapchak PA, Zhang JH. Translational stroke research guideline projections: the 20/20 standards. Transl Stroke Res. 2018;9:9–12.  https://doi.org/10.1007/s12975-017-0534-6.CrossRefPubMedGoogle Scholar
  12. 12.
    Lapchak PA, Zhang JH, Noble-Haeusslein LJ. RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Transl Stroke Res. 2013;4:279–85.  https://doi.org/10.1007/s12975-012-0209-2.CrossRefPubMedGoogle Scholar
  13. 13.
    Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology. 2010;74:1494–501.  https://doi.org/10.1212/WNL.0b013e3181dd42b3.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Marbacher S. Animal models for the study of subarachnoid hemorrhage: are we moving towards increased standardization? Transl Stroke Res. 2016;7:1–2.  https://doi.org/10.1007/s12975-015-0442-6.CrossRefPubMedGoogle Scholar
  15. 15.
    Marbacher S. Can quality improvement tools overcome the translational roadblock-the vital influence of the researcher. Transl Stroke Res. 2017;8:203–5.  https://doi.org/10.1007/s12975-017-0524-8.CrossRefPubMedGoogle Scholar
  16. 16.
    Marbacher S, Gruter B, Schopf S, Croci D, Nevzati E, D’Alonzo D, et al. Systematic review of in vivo animal models of subarachnoid hemorrhage: species, standard parameters, and outcomes. Transl Stroke Res. 2018.  https://doi.org/10.1007/s12975-018-0657-4.CrossRefGoogle Scholar
  17. 17.
    Stegmayr B, Eriksson M, Asplund K. Declining mortality from subarachnoid hemorrhage: changes in incidence and case fatality from 1985 through 2000. Stroke. 2004;35:2059–63.  https://doi.org/10.1161/01.STR.0000138451.07853.b6.CrossRefPubMedGoogle Scholar
  18. 18.
    Steiger HJ, Beez T, Beseoglu K, Hanggi D, Kamp MA. Perioperative measures to improve outcome after subarachnoid hemorrhage-revisiting the concept of secondary brain injury. Acta Neurochir Suppl. 2015;120:211–6.  https://doi.org/10.1007/978-3-319-04981-6_36.CrossRefPubMedGoogle Scholar
  19. 19.
    Suzuki H, Nakano F. To improve translational research in subarachnoid hemorrhage. Transl Stroke Res. 2018;9:1–3.  https://doi.org/10.1007/s12975-017-0546-2.CrossRefPubMedGoogle Scholar
  20. 20.
    van Lieshout JH, Dibue-Adjei M, Cornelius JF, Slotty PJ, Schneider T, Restin T, et al. An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage. Neurosurg Rev. 2017.  https://doi.org/10.1007/s10143-017-0827-y.CrossRefGoogle Scholar
  21. 21.
    Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391–5.  https://doi.org/10.1161/STROKEAHA.110.589275.CrossRefPubMedGoogle Scholar
  22. 22.
    Weir B, Grace M, Hansen J, Rothberg C. Time course of vasospasm in man. J Neurosurg. 1978;48:173–8.  https://doi.org/10.3171/jns.1978.48.2.0173.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Neurosurgery, Medical FacultyHeinrich-Heine-University DüsseldorfDüsseldorfGermany
  2. 2.Department of NeurosurgeryRadboudumc Medical CenterNijmegenThe Netherlands

Personalised recommendations